Liver Carcinoma — Trials

Liver Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

3,370 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 783
Recruiting: 463
Ph III recruiting: 41
Growth YoY: +1.5%
Industry share: 21%
Top sponsor: Sun Yat-sen University
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (387)

clinicaltrialsPublishedShowing 151–200 of 833 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05886465	HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial	unknown	Phase 2	40	Sun Yat-sen UniversityOTHER	1	Jun 2, 2023	clinicaltrials
NCT04631731	Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity(ICEMELT)	unknown	Phase 1 / Phase 2	200	Western Sydney Local Health DistrictOTHER	1	Jun 1, 2023